Buradasınız

Anasayfa » Content

Yöremizdeki Bakteriyel Keratitlerin Klinik Ve Mikrobiyolojik Özellikleri

Clinical and Microbiological Characteristics of Bacterıal Keratitis in Our Region

Journal Name:

  • Fırat Tıp Dergisi

Publication Year:

  • 2008

Key Words:

Keywords (Original Language):

Author NameUniversity of AuthorFaculty of Author
Abstract (2. Language): 
Objectives: To review the clinical and microbiological characteristics of bacterial keratitis in our ophthalmology department. Materials and methods: A retrospective analysis of the hospital records of 32 patients presenting with bacterial keratitis were analysed from January 2005 to January 2007. Results: The mean age of the patients were 53,6±24,9 and 52,25% (18) were older than 65 years. Presenting mean visual acuity was 0,085±0,185 log mar and mean final visual acuity was 0,145±0,299 log mar. As a major ocular risk factor, trauma was defined in 15,7% ( 5) patients. An organism was defined in 34,3% (11) patients. 73% (8) and 27% (3) of the isolates were Gram positive and Gram negative bacteria, respectively. Streptococcus species were the most common isolates (7,64%). Most of the bacterial isolates remained sensitive to currently available antibiotic preparations. 93,7% (30) of keratitis healed with therapy and 86,6% (26) of patients had visual acuity the same or better than the level at admission. 6,3% (2) had very poor visual outcome and keratoplasty were performed. Conclusion: Most of our patients with bacterial keratitis were healed with appropriate treatment. Trauma was the most important ocular risk factor. Elder population has an increased risk of developing keratitis.©200008, Firat University, Medical Faculty.
Bookmark/Search this post with
Abstract (Original Language): 
Amaç: Oftalmoloji kliniğimizdeki bakteriyel keratitlerin klinik ve mikrobiyolojik özelliklerini incelemek. Gereç ve Yöntem: Ocak 2005 ve Ocak 2007 yılları arasında bakteriyel keratit tanısı alan 32 hastanın kayıtları retrospektif olarak incelendi. Bulgular: Hastaların ortalama yaşı 53,6±24,9 ve %52,25 (18)' i 65 yaşından daha yaşlı idi. İlk geliş görme keskinlikleri 0,085±0,185 log mar, son görme keskinlikleri ise 0,145±0,299 log mar arasında idi. En önemli oküler risk faktörü olarak %15,7 (5) hastada travma saptandı. %34,3 (11) hastada organizma tanımlandı. İzolatların sırasıyla %73 (8)'ü Gram pozitif, %27 (3)'si Gram negatif idi. Streptococcus türleri en yaygın izolat idi (7, %64). İzole edilen bakterilerin çoğu günümüzde yaygın olarak kullanılan antibiyotiklere duyarlı idi. %93,7 (30) keratit tedavi ile iyileşti ve %86,6 (26) hastada görme keskinliği müracaat anındaki seviyede ya da bundan daha iyi idi. %6,3 (2) hastada görsel sonuçlar çok kötü oldu ve bunlara keratoplasti yapıldı. Sonuç: Bakteriyel keratitli hastalarımızın çoğu uygun tedavi ile iyileşti. Travma en önemli oküler risk faktörü idi. Yaşlı popülasyon keratit açısından artmış risk taşımaktadır. ©2008, Fırat Üniversitesi, Tıp Fakültesi
FULL TEXT (PDF): 
PDF icon arastrmx_135291_13_pp_235-238.pdf
  • 4
235-238
  • Turkish

REFERENCES

References: 

1. Whitcher JP, Srinivasan M, Upadhyay MP. Corneal blindness: A global perspective. Bull World Health Organ 2001; 79: 214-221.
2. Benson WH, Lanier JD. Current diagnosis and treatment of corneal ulcers. Curr Opin Ophthalmol 1998; 9: 45-49.
3. Schaefer F, Bruttin O, Zografos L, Guex-Crosier Y. Bacterial keratitis: A prospective clinical and microbiological study. Br J
Ophthalmol 2001; 85: 842-847
4. Bourcier T, Thomas F, Borderie V, Chaumeil C, Laroche L. Bacterial keratitis: Predisposing factors, clinical and microbiological review of 300 cases. Br J Ophtalmol 2003; 87:
834-838
5. Doğru M, Baykara M, Aygül F, Özmen A, Ertürk H, Özçetin H. Bakteriyel keratitli olgularda klinik deneyimimiz. Türkiye Klinikleri Oftalmoloji 2003; 12: 208-214
6.
Yılma
z S, Öztürk I, Türe M, Maden A. Mikrobiyal keratit tedavisinde 16 yıl. Türkiye Klinikleri Oftalmoloji 2008; 17: 1-6
7. Yalçın E, Karel F, Karaarslan A, Tekeli A. Kornea enfeksiyonlarının tanısında direk yayma, kültür ve antibiyogramın önemi. Medikal Network Oftalmoloji 1998; 5:
42-46.
8.
Hyndiu
k RA, Eiferman RA, Caldwell DR et al. Comparison of ciprofloxacin ophthalmic solution 0.3% to fortified tobramycin-cefazolin in treating bacterial corneal ulcers. Ciprofloxacin Bacterial Keratitis Study Group. Ophthalmol 1996; 103: 1854¬1862
9. Mallari PL, McCarty DJ, Daniell M, Taylor M. Increased
incidenc
e of corneal perforation after topical fluoroquinolone treatment for microbial keratitis. Am J Ophthalmol 2001; 131:
131-133.
10. Sharma V, Sharma S, Garg P, Rao GN. Clinical resistance of Staphylococcus keratitis to ciprofloxacin monotherapy. Indian J
Ophthalmol 2004; 52: 287-292.
11. Chaudhuri PR, Godfrey B. Treatment of bacterial corneal ulcers with concentrated antibiotic eye drop. Trans Ophthalmol Soc UK
1982; 102: 11-14
12. Alfonso E, Crider J. Ophthalmic infections and their anti-infective challenges. Surv of Ophthalmol 2005; 50: 51-56
13. Cohen EJ, Fulton JC, Hoffman CJ, Rapuano CJ, Laibson PR. Trends in contact lens-associated corneal ulcers. Cornea 1996;
15: 566-570
14. Coster DJ, Badenoch PR. Host, microbial, and pharmacological factors affecting the outcome of suppurative keratitis. Br J Ophthalmol 1987; 71: 96-101.
15. Dart JK, Stapleton F, Minassian D. Contact lenses and other risk factors in microbial keratitis. Lancet 1991; 338: 650-653.
16. Vajpayee RB, Dada T, Saxena R, Vajpayee M, Taylor HR, Vankatesh P, Sharma N. Study of the first contact management profile of cases of infectious keratitis: A hospital-based study.
Cornea 2000; 19: 52-56.
237
Fırat Tıp Dergisi 2008;13(4): 235-238
Güler ve Ark
17. Butler
TKH
, Spencer NA, Chan CCK, Singh Gilhotra J, 18. Oral Y, Özkurt Y, Rodop Ö, Benzonana N, Ustaoğlu R Doğan
McClellan K. Infective keratitis in older patients: A 4 year ÖK. Enfeksiyöz keratitlerin tedavisinde kültür ve antibiyogramın
review, 1998-2002. Br J Ophtalmol 2005; 89: 591-596 rolü. Türk Oftalmoloji Gazetesi 2001; 31: 18-21

Thank you for copying data from http://www.arastirmax.com